Sunday, March 17, 2019 10:31:16 PM
There is no JV or syndicate of any sort forming around MMEX-scam’s flawed scheme.
Anyone that understands project finance knows that the MMEX-scam scheme is filled with more holes than a sieve.
As a first order issue, if there were a legitimate opportunity for a PADD III inland refinery, a company, or syndicate of companies with access to legitimate capital would have already built it, or be completing it. MMEX-scam is beyond a day late, and multiple (hundreds) of millions of dollars short.
Anyone that understands project finance knows it simply doesn’t work the way that MMEX-scam is pursuing it. Everything that could possibly be wrong with MMEX-scam’s process is wrong, and then some.
Insolvent, super-dilutive OTC shell companies, with no business operations, no employees, no suppliers, no customers, no assets, sitting atop $40-million in cumulative losses and current liabilities are not financeable.
This is doubly true when the CEO is a fraudster, grifter, and con-man, with 30+ years of business failures.
When you are dead, you don't know that you are dead. It is difficult only for others. It is the same when you are stupid.
Recent MMEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:51:51 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/08/2024 02:30:21 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/03/2024 01:18:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 03:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 04:48:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 06:42:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/11/2023 08:50:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/17/2023 08:55:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM